Patents by Inventor Guy Eason

Guy Eason has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230270914
    Abstract: The present invention relates to a haemostatic material comprising a haemostat agent and a bioadhesive agent. Such a haemostatic material is useful, for example, in effectively controlling bleeding with a reduced compression period compared to the TCCC guidance of a minimum of three minutes compression using a haemostatic bandage.
    Type: Application
    Filed: January 23, 2023
    Publication date: August 31, 2023
    Inventors: Craig HARDY, Guy EASON, Andrew HOGGARTH
  • Patent number: 10973946
    Abstract: The present invention relates to a haemostatic material comprising a carrier layer and a material for wound contact comprising at least one haemostat in particulate, granular, powder, flake or short fibrous form. Such a haemostatic material is useful, for example, in reducing or stopping bleeding of a physiological target site in a person or animal, and can also be used to stem bleeding during medical procedures.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: April 13, 2021
    Assignee: Medtrade Products Limited
    Inventors: Craig Julian Hardy, Andrew Darby, Guy Eason
  • Patent number: 10828389
    Abstract: The present invention relates to a haemostatic material comprising a carrier layer and a material for wound contact comprising at least one haemostat in particulate, granular, powder, flake or short fibrous form. Such a haemostatic material is useful, for example, in reducing or stopping bleeding of a physiological target site in a person or animal, and can also be used to stem bleeding during medical procedures.
    Type: Grant
    Filed: May 22, 2015
    Date of Patent: November 10, 2020
    Assignee: Medtrade Products Limited
    Inventors: Craig Julian Hardy, Andrew Darby, Guy Eason
  • Patent number: 9750843
    Abstract: The present invention relates to a haemostatic material comprising a carrier layer and a material for wound contact comprising at least one haemostat in particulate, granular, powder, flake or short fibrous form. Such a haemostatic material is useful, for example, in reducing or stopping bleeding of a physiological target site in a person or animal, and can also be used to stem bleeding during medical procedures.
    Type: Grant
    Filed: April 27, 2009
    Date of Patent: September 5, 2017
    Assignee: MEDTRADE PRODUCTS LIMITED
    Inventors: Craig Hardy, Andrew Darby, Guy Eason
  • Patent number: 9370451
    Abstract: A medical device for delivery of a therapeutic agent to a physiological target site includes a flexible receptacle containing said therapeutic agent, wherein at least a part of the receptacle is formed of a water-soluble or water-dispersible material. The therapeutic agent may include a haemostatic agent and the physiological target site may be a wound.
    Type: Grant
    Filed: November 16, 2007
    Date of Patent: June 21, 2016
    Assignee: MEDTRADE PRODUCTS LIMITED
    Inventors: Craig Julian Hardy, Stewart Andrew Darby, Andrew Guy Eason
  • Publication number: 20160128679
    Abstract: A tool for application of a haemostat to a site of bleeding comprises a cylindrical barrel, a plunger slidable in the barrel, the barrel having an outlet end. The outlet end may be configured as a cone or rounded end with a central aperture and longitudinal slots in a cruciform arrangement, or may be left open. The barrel may have a slot alignable with a slot in an inner member for insertion of a haemostat body in the barrel. The barrel and plunger may be separable for insertion of the body into an open end of the barrel.
    Type: Application
    Filed: January 25, 2008
    Publication date: May 12, 2016
    Applicant: Med-Trade Products Limited
    Inventors: Craig Julian Hardy, Guy Eason, Kathryn Sharafanowich
  • Publication number: 20150306274
    Abstract: The present invention relates to a haemostatic material comprising a carrier layer and a material for wound contact comprising at least one haemostat in particulate, granular, powder, flake or short fibrous form. Such a haemostatic material is useful, for example, in reducing or stopping bleeding of a physiological target site in a person or animal, and can also be used to stem bleeding during medical procedures.
    Type: Application
    Filed: May 22, 2015
    Publication date: October 29, 2015
    Applicant: MEDTRADE PRODUCTS LIMITED
    Inventors: Craig Julian Hardy, Andrew Darby, Guy Eason
  • Publication number: 20140105950
    Abstract: The present invention relates to a haemostatic material comprising a haemostat agent and a bioadhesive agent. Such a haemostatic material is useful, for example, in effectively controlling bleeding with a reduced compression period compared to the guidance of a minimum of three minutes compression using a haemostatic bandage.
    Type: Application
    Filed: March 12, 2012
    Publication date: April 17, 2014
    Applicant: MEDTRADE PRODUCTS LIMITED
    Inventors: Craig Hardv, Guy Eason, Andrew Hoggarth
  • Publication number: 20110052665
    Abstract: The present invention relates to a haemostatic material comprising a carrier layer and a material for wound contact comprising at least one haemostat in particulate, granular, powder, flake or short fibrous form. Such a haemostatic material is useful, for example, in reducing or stopping bleeding of a physiological target site in a person or animal, and can also be used to stem bleeding during medical procedures.
    Type: Application
    Filed: April 27, 2009
    Publication date: March 3, 2011
    Applicant: MED-TRADE PRODUCTS LIMITED
    Inventors: Craig Hardy, Andrew Darby, Guy Eason
  • Publication number: 20100092525
    Abstract: A medical device for delivery of a therapeutic agent to a physiological target site includes a flexible receptacle containing said therapeutic agent, wherein at least a part of the receptacle is formed of a water-soluble or water-dispersible material. The therapeutic agent may include a haemostatic agent and the physiological target site may be a wound.
    Type: Application
    Filed: November 16, 2007
    Publication date: April 15, 2010
    Applicant: MEDTRADE PRODUCTS LIMITED
    Inventors: Craig Julian Hardy, Stewart Andrew Darby, Andrew Guy Eason